| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |